Astura Medical, a high growth, innovative spine technology company, announced today the completion of the initial surgeries and full commercial release for its BRIDALVEIL Occipital-Cervico-Thoracic (OCT) System. The first cases were successfully completed at multiple hospitals across the country, including at the University of Colorado Hospital by Dr. David Ou-Yang, Assistant Professor of Orthopedics.

“Our practice addresses a wide range of complex conditions, so I’m always looking for the most advanced technology to meet our surgical demands,” said Dr. Ou-Yang. “Bridalveil OCT has not only met those demands, but it has continued to exceed my expectations. The versatility of the instrumentation, coupled with the breadth of implants offered has enhanced our ability to treat even the most complex cases. It is the most comprehensive and one of the most user friendly posterior cervical systems I’ve used from any company, large or small.”

“We are extremely proud of the feedback and success we’ve seen with Bridalveil OCT since our initial release of the system,” said Joel Gambrell, President and CEO of Astura Medical. “It allows us to continue to expand upon our goal of providing market leading technology to our growing network of surgeon and distributor partners.”

Designed with the most complex and demanding cases in mind, BRIDALVEIL OCT provides a comprehensive offering of screw options (single-lead, dual-lead, high-top, and smooth shank) ranging from 3.5mm to 5.5mm in diameter that are compatible with either a 3.5mm or 4.0mm rod in titanium or cobalt chrome. The system additionally provides an extensive line of connectors, transition rods, and instrumentation options to allow surgeons the ability to seamlessly transition across multiple segments of the spine.

Astura Medical, a high growth, innovative spine technology company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Company’s BRIDALVEIL Occipital-Cervico-Thoracic (OCT) System.

“The FDA 510(k) clearance of our BRIDALVEIL OCT System, demonstrates the power of our innovation engine at Astura Medical and represents our best system released to date. We are excited for the opportunity to provide our rapidly expanding group of surgeon partners the most complete OCT technology offering on the market today, to further enhance their ability to provide the best in patient care,” said Thomas Purcell, Vice President.

Designed with the most complex and demanding cases in mind, BRIDALVEIL OCT provides a comprehensive offering of screw options (single-lead, dual-lead, high-top, and smooth shank) ranging from 3.5mm to 5.5mm in diameter that are compatible with either a 3.5mm or 4.0mm rod in titanium or cobalt chrome. The system also provides an extensive line of connectors, transition rods, and instrumentation options to allow surgeons the ability to seamlessly transition across multiple segments of the spine.

The launch of BRIDALVEIL OCT represents the 11th system launched since the company was founded in 2014. The company anticipates high demand for BRIDALVEIL OCT in addition to the robust growth seen in its current line of products.

Astura Medical will be showcasing BRIDALVEIL OCT, along with the Company’s other systems at Exhibit 565 during the 32nd North American Spine Society (NASS) Annual Meeting, taking place in Orlando, October 24-27th.